DNA Sequencing and Medical Discovery Diagnostic Applications The ability to rapidly know the exact cause of an ailment or disease is the first and often a difficult challenge in the path to recovery. A symptom or set of symptoms can point to a number of different conditions. Diagnostic approaches are employed to decipher the historical […]
Macrogen Corp., one of the leading providers of next-generation sequencing services, has been announced as a participating provider in precisionFDA. The precisionFDA web platform is part of President Obama’s vision with his Precision Medical Initiative announced last year. The administration’s goal is to move away from a “one-size-fits-all” approach to medicine and move towards a […]
The emergence and growth of whole genome sequencing technologies, and the resulting immense database generated, requires that scientists and medical professionals learn more about the powerful tools available to them. These tools give scientists the ability to interpret and apply the information and are becoming increasingly available. Genomic technologies have bolstered the power of personalized […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.
inquiry@nullpsomagen.com
(301) 251-1007
ROCKVILLE, MARYLAND (HQ)
CLIA: 21D2062464 | CAP: 8742212
BROOKLYN, NEW YORK
CAMBRIDGE, MASSACHUSETTS
STERLING, VIRGINIA
CLIA: 49D2172599
KOSDAQ: PSOMAGEN INC (950200)
